Citation: Regina v Thomas William Hudson [2007] NSWDC 260
Court: District Court of New South Wales
Date: 9 February 2007
Judge(s): Finnane QC DCJ
Background
The offender, a man born in 1947 with little formal education, was convicted after a lengthy trial of three drug-related offences: attempting to manufacture ephedrine, attempting to manufacture methylamphetamine, and conspiring with others to manufacture ephedrine over an extended period between 2003 and 2005. He was the only one of four co-offenders to contest the charges at trial. The maximum penalty for each offence was 15 years imprisonment and a $220,000 fine.
The offending involved a loose network of individuals, led in practical terms by a co-offender who was a trained pharmacist (referred to in this post as the pharmacist co-offender). The offender's role was largely logistical: he provided his home as a delivery address for chemicals, allowed a fictitious company name to be placed on his letterbox, received chemicals ordered under false names, and permitted use of his fax and computer. He was also present at an attempted manufacture in a regional location and later participated in an attempt to produce methylamphetamine at another property.
The enterprise was commercially motivated, with approximately $40,000 contemplated. It was, however, almost entirely unsuccessful. The substances produced were of poor quality and unsaleable, and the pharmacist co-offender's attempts yielded only a pink rock substance rather than usable ephedrine.
Legal Issues
- What sentence was appropriate for the offender's role in the conspiracy and related offences, having regard to the sentences imposed on co-offenders?
- How should parity of sentencing be applied where co-offenders pleaded guilty and cooperated with the Crown, but this offender did not?
- What weight should be given to the offender's age, prospects of rehabilitation, remorse, and likelihood of re-offending?
- Were there special circumstances justifying a longer than standard balance of term after the non-parole period?
Decision
The court sentenced the offender to three years imprisonment on each count, to be served concurrently, with a non-parole period of three years and a balance of term of two years. The sentences ran from 17 August 2006. The court addressed parity by reference to the sentences given to the pharmacist co-offender (non-parole period of two years, balance of one year) and another co-offender sentenced by a different judge (non-parole period of twelve months, balance of fifteen months). Both had pleaded guilty; neither had received discounts for assistance to the Crown.
The court found that the offender's sentence should be more severe than those of his co-offenders for several reasons. He did not plead guilty, showed no remorse, and advanced what the court found to be manifestly false defences, including a partial alibi relying on a woman long presumed murdered and an attempt to blame co-offenders who were, on the evidence, less culpable than portrayed. The court also noted that the offender had given false evidence during the trial.
On rehabilitation and special circumstances, the court found little room for optimism. The offender's age (then 59) was acknowledged as a factor that might reduce the likelihood of future offending by making continued involvement in drug manufacture physically difficult. The court found no significant special circumstances to justify extending the balance of term beyond the standard ratio, noting there was little evidence of genuine prospects of rehabilitation or demonstrated remorse.
The court acknowledged that the overall venture had been wholly unsuccessful and that nothing of commercial value was ever produced, but treated this as having limited bearing on the seriousness of the offending, given the clear intent to manufacture and sell prohibited drugs.
Orders Made
- Three years imprisonment imposed on each of the three counts, to be served concurrently.
- Non-parole period of three years, running from 17 August 2006 to 16 August 2009.
- Balance of term of two years, running from 17 August 2009 to 16 August 2011.
- Release to parole on 16 August 2009.
- All illegal drugs the subject of the proceedings to be destroyed after the appeal period expires.
Key Takeaways
- The District Court applied parity principles by comparing the offender's sentence with those of co-offenders, but imposed a longer sentence to reflect his contested trial, absence of remorse, and advanced of what the court found to be false defences.
- A lack of remorse, combined with false testimony and attempts to shift blame to less culpable co-offenders, are sentencing factors that can justify a departure upward from the sentences received by co-offenders who pleaded guilty.
- Where a conspiracy to manufacture prohibited drugs involves a hierarchical structure, a court will assess each participant's role individually; a logistical role does not automatically attract a lesser sentence where the participant was a knowing and willing participant throughout the conspiracy.
- The complete failure of an illegal manufacturing enterprise to produce a usable or saleable product does not, of itself, significantly reduce the gravity of the offending or the sentence imposed.
- Advanced age may be treated as a factor bearing on prospects of re-offending, though it does not automatically constitute a special circumstance justifying a longer balance of term beyond the non-parole period.
Legislation and Cases Referenced
Legislation: No specific legislation was cited in the judgment text or metadata.
Cases: No specific cases were cited in the judgment text or metadata.
Note: The maximum penalty referenced in the judgment (15 years imprisonment and a $220,000 fine) relates to the drug manufacturing and conspiracy offences charged, though the precise statutory provisions were not identified in the judgment as reported.